UF researcher leads study to understand why more men die from COVID-19 than women.
UF Health researcher Barry Byrne, M.D., Ph.D. is working to develop a COVID-19 vaccine.
Three vaccines are now available to stem the pandemic, and for many, hope is increasing that a future free from the fear of COVID-19 is near.
An antibiotic used to treat leprosy is among a handful of existing drugs that could attack and slow the spread of the United Kingdom variant of the SARS-CoV-2 virus that causes COVID-19, a University of Florida Health researcher has found.
Guilt and shame are two prevailing emotions surrounding COVID-19. This guilt stems in part from the fact that anyone could be a potential carrier of the virus.
Members in UF’s Warren B. Nelms Institute, CISE and ECE are developing an affordable wearable device that indicates appropriate social distancing.
UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.
In a project with the UF Informatics Institute SEED Fund, the Departments of UF Sociology and UF Linguistics will study different topics on COVID-19.
A trio of interdisciplinary UF researchers are searching for genes that either hasten or thwart the growth of SARS-CoV-2 virus inside a human host. Their results may contribute to the search for a COVID-19 drug or therapeutic arsenal.
The director of the University of Florida’s Center for Smell and Taste and the co-director of the UF Health Smell Disorders Program answer questions about this emerging trend.
Loss of smell occurs with the common cold and other viral infections of the nose and throat.
UF Health researchers look into crucial study on older adults living in The Villages® .